US equities |
TSLA $396.35 ▲+6.48% MU $906.49 ▲+3.30% SPCX $149.56 ▲+1.40% NVDA $217.11 ▲+2.92% META $642.56 ▼-0.01% SNDK $1,261.10 ▲+1.86% AAPL $346.67 ▼-0.30% AMD $528.83 ▲+2.33%
FinancialContent

Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.055 -0.025 (-0.81%)
Delayed Quote Updated: 11:19 AM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
22 23 Next >
News headline image
Why Shares of Ardelyx Were Down Wednesday ↗
The company's hopes for approval of a drug to treat chronic kidney disease took a hit. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Ardelyx Shares Preliminary Data on Use of IBSRELA® (tenapanor) in Pediatric IBS-C Patients at NASPGHAN 2023
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Analyst Expectations for Ardelyx's Future ↗
 
Via Benzinga
Ardelyx Inc. (NASDAQ: ARDX) is a Stock Spotlight on 8/30
Via Investor Brand Network
News headline image
Earnings Outlook For Ardelyx ↗
 
Via Benzinga
News headline image
Jim Cramer Likes This Oil Giant Up Almost 28% In A Year — 'It Has Room To Grow' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Caterpillar Inc. (NYSE: CAT). 
Via Benzinga
News headline image
Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Tenapanor for Hyperphosphatemia Approved in Japan
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
The 3 Best Penny Stocks to Buy Now: September 2023 ↗
When all the focus lies on the largest names of the economy, these best penny stocks to buy offer a great risk/reward ratio. 
Via InvestorPlace
Topics Economy
News headline image
Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 ↗
 
Via Benzinga
News headline image
The 3 Most Promising Penny Stocks to Own Now ↗
Explore top penny stock picks, not just whims but for powerhouses poised for exponential growth over the long term. 
Via InvestorPlace
News headline image
3 Penny Stocks You’ll Regret Not Buying Soon ↗
There are plenty of penny stocks to buy, but not all of them are created equal. Here are some of the best options to choose from. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023 ↗
 
Via Benzinga
News headline image
Hibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Don’t Sleep on These 3 Penny Stocks That Will Mint Millionaires ↗
These top three penny stocks are the ones to buy that will mint your investment status to a millionaire in returns. 
Via InvestorPlace
News headline image
5 Meme Stocks to Sell Immediately, According to AI ↗
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now ↗
One of the safest sectors on the market is biotech. Here are three cheap biotech stocks to buy that are good options for investors. 
Via InvestorPlace
News headline image
Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
Conference call scheduled for 8:00 a.m. Eastern Time 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
Acceptance of NDA Submission triggers as $2 million milestone payment to Ardelyx by Fosun Pharma 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Present at the Jefferies 2023 Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
22 23 Next >